News Focus
News Focus
Followers 4
Posts 319
Boards Moderated 0
Alias Born 04/04/2024

Re: None

Thursday, 04/23/2026 1:25:54 PM

Thursday, April 23, 2026 1:25:54 PM

Post# of 519007
Without a full P3 trial which, with 1000 people costs $200-$300 million Anavex is dead in the water. And that will require massive dilution IF they can find a market for that many shares. No BP is going to touch them present state. Given no concrete announcements I think Missling is just milking this company. Maybe, just maybe, the EMA had it right. I personally put my $$ into a different biotech but that is a different story with a positive kick to it. Good luck longs.......
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News